These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25849622)

  • 1. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
    Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
    Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
    Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells.
    Schnittker D; Kwofie K; Ashkar A; Trigatti B; Richards CD
    Mediators Inflamm; 2013; 2013():317503. PubMed ID: 24307759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta.
    Faffe DS; Flynt L; Mellema M; Whitehead TR; Bourgeois K; Panettieri RA; Silverman ES; Shore SA
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1040-8. PubMed ID: 15665043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
    Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
    Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
    Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.
    Faffe DS; Flynt L; Mellema M; Moore PE; Silverman ES; Subramaniam V; Jones MR; Mizgerd JP; Whitehead T; Imrich A; Panettieri RA; Shore SA
    J Allergy Clin Immunol; 2005 Mar; 115(3):514-20. PubMed ID: 15753898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
    Langdon C; Kerr C; Tong L; Richards CD
    J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
    Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17--induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB.
    Wuyts WA; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE; Demedts MG; Verleden GM
    J Heart Lung Transplant; 2005 Jul; 24(7):875-81. PubMed ID: 15982617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways.
    Smyth DC; Kerr C; Li Y; Tang D; Richards CD
    Cell Signal; 2008 Jun; 20(6):1142-50. PubMed ID: 18372159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
    El Mabrouk M; Sylvester J; Zafarullah M
    Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
    Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
    Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6.
    Fritz DK; Kerr C; Tong L; Smyth D; Richards CD
    J Immunol; 2006 Apr; 176(7):4352-60. PubMed ID: 16547273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L; Smyth D; Kerr C; Catterall J; Richards CD
    Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.